M&A Deal Of The Year-1

Hosted by

Baker McKenzie 300x

Presented by

Roel Meers

Roel Meers, Corporate Finance Partner, Baker McKenzie




This award recognises the teams and organisations who have executed a truly transformational and high value M&A deal for both the company and the wider industry. 

Qualifying criteria

  • The lead company must be a European Life Science company
  • Open to private, public companies, pharma, commercial leaders or big tech
  • Deal must be an M&A deal NOT a license, partnership or alliance
  • Deal to have completed in the period between 1 October 2022 and 1 October 2023

Judges will be paying particular attention to:

  • Uniqueness or novelty of deal strategy / terms and structure
  • Level of value creation / size of deal
  • Strength of acquirers existing pipeline / synergy with existing portfolio
  • Potential game / industry changing implications within next 12-months
  • Post-deal performance
This year's finalists will be scored between the period of 1-7th November, with winner and podium places exclusively announced on the evening of the 13th November at the Honourable Artillery Company venue in London, during the 2023 European Lifestars Awards Reception, Gala Dinner and Ceremony. Tickets can be purchased via https://www.lsxleaders.com/lifestars-awards/tickets 

Congratulations to the 2023 joint winners and podium



M&A of the Year